Medicina e Alimentazione Biomolecolare: il nuovo paradigma di fronte alla pandemia silenziosa dell'inquinamento ambientale
on August 18, 2026

Biomolecular Medicine and Nutrition: the new paradigm in the face of the silent pandemic of environmental pollution

Contemporary medicine is facing a profound shift in nosological frameworks, driven by the emergence of the so-called "new patient". This clinical condition is the result of chronic poisoning, slow and initially asymptomatic, caused by continuous exposure to environmental pollution factors. Over the last seven decades, the chemical industry has introduced over 100,000 synthetic substances — including solvents, heavy metals, pesticides, and endocrine disruptors — that have come into direct contact with the population (Montagnier, 2008).

The World Health Organization highlights that, among 133 highly prevalent human diseases, as many as 101 show a direct etiopathogenic correlation with the environment, defining this phenomenon as a true "silent pandemic". Xenobiotic substances act as aggravating factors in a context already compromised by sedentary lifestyles, obesity, polypharmacy, and self-medication. In my book "Biomolecular Nutrition", we address precisely this emergency: how the nutritional and medical approach must evolve to protect the host's biological terrain.

Etiopathogenesis and Tissue Dynamics of Pollutants

Environmental pollutants enter the body predominantly through the gastrointestinal tract (up to 70%), followed by the respiratory system and the skin. Studies conducted on the European population indicate the simultaneous presence of an average of about 300 synthetic toxic substances within individual tissues (Montagnier, 2008).

These exogenous molecules act as oxidizing agents, increasing the production of reactive oxygen species (ROS) or free radicals. The primary target is represented by biomolecules, the microscopic functional units of the cell and the colloid. The preservation of the electromagnetic charges and the three-dimensional conformation of these molecular structures is essential for the stability of the matrix and for the maintenance of biological harmony (Oschman, 2000).

The body activates its own antioxidant defense systems (superoxide dismutase, catalase, glutathione peroxidase) and hepatic detoxification pathways (phases I and II of biotransformation). However, the persistence of chemical insult leads to the depletion of these reserves, triggering structural damage and organ dysfunction.

The initial systemic distribution of pollutants evolves toward a selective tissue reorganization, influenced by the physicochemical properties of the molecules:

·        Adipose Tissue: Selective accumulation of lipophilic substances, hydrocarbons, and organochlorine pesticides.

·        Brain: Selective concentration in the gray matter of neurotoxic metals and solvents.

·        Bone Tissue and Epiphyses: Fixation of heavy metals at the level of the cartilaginous growth zones and stem cell niches.

·        Liver: Intense retention of toxic compounds related to the activity of the cytochrome P450 system.

The final placement of toxins varies from individual to individual based on the "host condition" or "predisposition terrain", generating a complex clinical picture, devoid of standardized patterns and characterized by symptomatic overlaps.

Susceptibility of Species and Complex Clinical Pictures

Pediatric and female populations show a particular vulnerability to environmental poisoning:

·        Children: The high ratio between absorption surface and body mass determines a proportionally greater intake of toxins (Curci, 2005). Placental contamination by exposed mothers leads to the emergence of pathologies already in the first months of life, such as food intolerances, manifestations of the autism spectrum, hearing loss, and psycho-pedagogical deficits in school age.

·        Women: A greater reactivity of the immune and endocrine systems (Bottaccioli, 2005) predisposes to a higher incidence of hormonal dysfunctions, autoimmune diseases, and hypersensitivity conditions.

The compromise of the molecular and cellular microenvironment translates into a wide spectrum of pathological conditions involving different districts:

·        Metabolic and Oxidative District: Depletion of antioxidant reserves and local acidosis with manifestations such as chronic fatigue, fibromyalgia, and hepatic steatosis.

·        Immune System: Th1/Th2 imbalance and increased intestinal permeability with the emergence of atypical autoimmune diseases, allergies, and Multiple Chemical Sensitivity (MCS).

·        Integumentary System: Alteration of the dermal matrix and cutaneous microcirculation that favor atypical acne, early striae, psoriform lesions, and rosacea.

·        Neurological System: Damage to myelin sheaths and chronic neuroinflammation correlated with Parkinson's, Alzheimer's, early-onset dementias, and autonomic neuropathies.

·        Cardiovascular System: LDL oxidation and damage to vascular collagen and elastin with accelerated atheromatosis, vasculopathies, and cerebrovascular events.

·        Genetic and Reproductive System: Direct DNA damage and action of endocrine disruptors with consequent infertility, spontaneous abortion, congenital malformations, and neoplasms.

·        Osteoarticular System: Epiphyseal accumulation of metals and depletion of stem cells that cause accelerated osteochondral degeneration and severe discopathies.

Patients suffering from chronic systemic poisoning frequently present for medical observation with normal routine laboratory tests and imaging studies. This discrepancy creates difficulties in the doctor-patient relationship and delays the establishment of an adequate therapeutic pathway.

The Therapeutic Approach: The Role of Biomolecular Nutrition

In the face of this complex clinical reality, Medicine and Biomolecular Nutrition consider the body as an integrated system whose efficiency depends on the quality of the colloidal structure and the correct biophysical and electromagnetic balance. As I elaborate in the book "Biomolecular Nutrition", the primary goal is not simply to treat the symptom or the already established organic disease, but to identify and correct the functional and molecular alterations that precede it (Zabala Begnis, 2010).

The biomolecular assessment and intervention plan use targeted tools:

1.      Assessment of Oxidative Stress and Antioxidant Capacity: Free radical analysis to quantify the degree of molecular distress and establish a personalized nutritional restoration.

2.      Analysis of Toxins and Heavy Metals: Determination of the accumulation of xenobiotic substances in tissues through mineralogram or specific tests, to modulate biological chelation pathways.

3.      Study of Permeability and Food Intolerances: Analysis of the intestinal barrier to remove pro-inflammatory foods and restore the selectivity of the digestive mucosa.

4.      Biophysical and Electromagnetic Assessment of the Colloid: Monitoring the hydration status and tissue conductivity to restore the physiological charge of biomolecules (Oschman, 2000).

5.      Personalized Nutritional and Nutraceutical Strategies: Use of foods not only as an energy source, but as true genetic informers and antioxidant remedies capable of restoring the extracellular matrix.

The integration of this data allows for the structuring of a unique preventive, predictive, and curative protocol for each patient. Understanding Biomolecular Nutrition means acquiring the keys to detoxify the cellular colloid, protect the DNA, and restore the body's natural capacity for healing and self-regulation.

Bibliography

1.      Bottaccioli, F. (2005). Psychoneuroendocrinoimmunology. The Scientific Basis of Integrated Mind-Body Care. Red Edizioni, Milan.

2.      Curci, O. (2005). Clinical Toxicology. La Prensa Médica Argentina.

3.      Montagnier, L. (2008). Les combats de la vie. Éditions JC Lattès, Paris.

4.      Neira, M. (2016, March 15). Interview on environmental health and related diseases. La Nación newspaper.

5.      Oschman, J. L. (2000). Energy Medicine: The Scientific Basis. Churchill Livingstone / Elsevier Science.

6.      Zabala Begnis, E. (2010). Biomolecular Medicine and Colloidal Pathophysiology. La Prensa Médica.

Edited by Nico Martini